TFX News and Press, Teleflex Incorporated From 08/30/23

WAYNE, Pa., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 21st Annual Global Healthcare Conference at the Sheraton New York, on Wednesday, September 13, 2023, at 11:30 a.m. (ET). A li...

2023-08-29 13:29:41 ET More on IHI IHI: Too Expensive Considering Long-Term Rate Uncertainty Johnson & Johnson’s MedTech performance rallies industry Life science tools industry drags healthcare in S&P 500 MedTech, hospital stocks slump after T...

WAYNE, Pa., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the release of the Arrow ™ ErgoPack ™ Complete Kits with Hemodialysis and Large Bore catheters in the United States. This updat...

2023-08-14 16:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-08-03 11:58:02 ET Teleflex, Inc. (TFX) Q2 2023 Earnings Conference Call August 03, 2023, 08:00 ET Company Participants Lawrence Keusch - VP, IR & Strategy Development Liam Kelly - Chairman, President & CEO Thomas Powell - EVP & CFO Conferen...

2023-08-03 06:45:32 ET Teleflex press release ( NYSE: TFX ): Q2 Non-GAAP EPS of $3.41 beats by $0.20 . Revenue of $743.3M (+5.5% Y/Y) beats by $13.41M . 2023 guidance summary Raising GAAP revenue growth guidance to 5.80% to 6.55% Raising the low end of ...

WAYNE, Pa., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the second quarter ended July 2, 2023. Second quarter financial summary Revenues of $743.3 million, up 5.5% com...

2023-08-02 15:03:50 ET Teleflex ( NYSE: TFX ) is scheduled to announce Q2 earnings results on Thursday, August 3rd, before market open. The consensus EPS Estimate is $3.21 (-5.3% Y/Y) and the consensus Revenue Estimate is $729.89M (+3.6% Y/Y). Over the last 2 years, TF...

WAYNE, Pa., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the U.S Food and Drug Administration (FDA) has cleared the QuikClot Control+ ™ Hemostatic Device to include mild and moderate bleeding in ...

2023-07-27 15:05:43 ET Summary Teleflex Incorporated saw a tougher 2022, but has found some operating momentum again. The company is using this momentum to announce its next bolt-on deal, being strategic but a bit expensive. Following a 20% re-rating over the past year, I thin...